Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Opsin 1, short-wave-sensitive (OPN1SW) is a **G protein-coupled receptor** located in the cone cells of the human retina and is responsible for the absorption of **short-wavelength (blue/violet) light**, enabling blue color vision[2][3][5][10]. OPN1SW is essential for normal color discrimination and initiates phototransduction by triggering a signaling cascade upon light absorption in “S” (short-wavelength) cones[2][3]. Mutations in OPN1SW are associated with **tritanopia**, a rare form of inherited color vision deficiency characterized by the inability to distinguish blue from yellow, and with less severe abnormal S-cone function known as tritanomaly[2][5]. The molecule is classified in the rhodopsin-like GPCR family and shares structural properties with other opsins but is specifically tuned to blue light[1][5]. No approved drugs target OPN1SW, but molecular and genetic tests are available for research and clinical diagnostics of related color vision deficiencies[2][5].
Not applicable (no known drugs targeting OPN1SW); opsin function is intrinsic to visual signaling and not the current subject of drug modulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Opsin 1, short-wave-sensitive (blue cone photoreceptor pigment) (OPN1SW).